The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 106, Issue 2, Pages 199-212
Publisher
Springer Nature
Online
2010-11-02
DOI
10.1038/ajg.2010.392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
- (2010) Waqqas Afif et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
- (2010) Stefan Schreiber et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study
- (2010) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
- (2010) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of genetics in prediction of disease course and response to therapy
- (2010) Severine Vermeire WORLD JOURNAL OF GASTROENTEROLOGY
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
- (2009) G. R. LICHTENSTEIN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The efficacy and safety of a third anti-TNF monoclonal antibody in Crohnâs disease after failure of two other anti-TNF antibodies
- (2009) M. ALLEZ et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
- (2009) Pierre Lozeron et al. ARCHIVES OF NEUROLOGY
- Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients
- (2009) Liesbet Henckaerts et al. Clinical Gastroenterology and Hepatology
- Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
- (2009) Konstantinos Karmiris et al. GASTROENTEROLOGY
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for the treatment of fistulas in patients with Crohn's disease
- (2009) J-F Colombel et al. GUT
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
- (2009) I. Arijs et al. GUT
- Durability of infliximab in Crohnʼs disease
- (2009) Jason E. Gonzaga et al. INFLAMMATORY BOWEL DISEASES
- Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
- (2009) Andrea Cassinotti et al. INFLAMMATORY BOWEL DISEASES
- Overall and cause-specific mortality in Crohnʼs disease: A meta-analysis of population-based studies
- (2009) Dana Duricova et al. INFLAMMATORY BOWEL DISEASES
- P183 - Predictive factors for a mild course of Crohn's disease
- (2009) B. Bokemeyer et al. Journal of Crohns & Colitis
- European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2009) J.F. Rahier et al. Journal of Crohns & Colitis
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
- (2009) Gert Van Assche et al. Journal of Crohns & Colitis
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Predicting Factors of Fistula Healing and Clinical Remission After Infliximab-Based Combined Therapy for Perianal Fistulizing Crohn’s Disease
- (2008) David Tougeron et al. DIGESTIVE DISEASES AND SCIENCES
- 494 Efficacy and Safety of Certolizumab Pegol in Patients with Active Crohn's Disease Who Previously Lost Response or Were Intolerant to Infliximab: Open-Label Induction Preliminary Results of the Welcome Study
- (2008) Severine Vermeire et al. GASTROENTEROLOGY
- 921 Long Term Follow-Up of a Cohort of Steroid-Dependent Crohn's Disease Patients Included in a Randomized Trial Evaluating Short Term Infliximab Combined with Azathioprine
- (2008) Laurent Costes et al. GASTROENTEROLOGY
- Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study
- (2008) Brian G. Feagan et al. GASTROENTEROLOGY
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
- (2008) Murat Toruner et al. GASTROENTEROLOGY
- Optical Contrast Endoscopy: Is It Ready for Routine Use?
- (2008) Jonathan Cohen GASTROENTEROLOGY
- Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
- (2008) Miguel Regueiro et al. GASTROENTEROLOGY
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
- (2008) F Schnitzler et al. GUT
- Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohnʼs disease: A randomized, double-blind, placebo-controlled pilot study
- (2008) Kelvin T. Thia et al. INFLAMMATORY BOWEL DISEASES
- European evidence-based Consensus on the management of ulcerative colitis: Current management
- (2008) S.P.L. Travis et al. Journal of Crohns & Colitis
- European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
- (2008) E.F. Stange et al. Journal of Crohns & Colitis
- Long-term outcome after infliximab for refractory ulcerative colitis
- (2008) Marc Ferrante et al. Journal of Crohns & Colitis
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
- Predictors of severe Crohn's disease
- (2008) Catherine Loly et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now